0001140361-20-015090.txt : 20200629
0001140361-20-015090.hdr.sgml : 20200629
20200629214722
ACCESSION NUMBER: 0001140361-20-015090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200629
DATE AS OF CHANGE: 20200629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ELMS STEVE
CENTRAL INDEX KEY: 0001250195
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36570
FILM NUMBER: 201000121
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 29TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zosano Pharma Corp
CENTRAL INDEX KEY: 0001587221
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454488360
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34790 ARDENTECH COURT
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-1200
MAIL ADDRESS:
STREET 1: 34790 ARDENTECH COURT
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: ZP Holdings Inc
DATE OF NAME CHANGE: 20130919
4
1
form4.xml
FORM 4
X0306
4
2020-06-25
0001587221
Zosano Pharma Corp
ZSAN
0001250195
ELMS STEVE
C/O ZOSANO PHARMA CORPORATION
34790 ARDENTECH COURT
FREMONT
CA
94555
true
Common Stock
2020-06-25
4
A
0
7500
0
A
7500
D
Common Stock
2718266
I
See Footnote
Represents restricted stock units which vest in a single installment on the first anniversary of June 3, 2020, subject to the Reporting Person's continued service to the Issuer on
the vesting date.
Represents shares directly held by Aisling Capital IV, LP ("Aisling"), and which may be deemed to be beneficially owned by Aisling Capital Partners IV, LP ("Aisling GP"), as
general partner of Aisling, Aisling Capital Partners IV LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members and partners
(collectively, the "Managers") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms, who have shared voting and dispositive
power over the shares. Mr. Elms disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
/s/ Steven Lo, Attorney-in-Fact for Steve Elms
2020-06-29